Remove 2008 Remove Access Remove History Remove Treatment
article thumbnail

Oregon is Setting the Foundation for its Psilocybin Therapy Program

Veriheal

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98
article thumbnail

UW-Madison Is Diversifying Psychedelic Research

Veriheal

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy.

Therapy 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). It also has an extensive and diverse history of medicinal use. 2016 ; Sznitman et al.

article thumbnail

Behind the Scenes on Cannabis Normalization With JM Pedini

The Cannigma

By sufficiently moving the needle on public opinion, NORML aims to legalize the responsible use of marijuana by adults, and subsequently ensure access to products that are safe, convenient, and affordable. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca. Let’s have a listen.

Access 81
article thumbnail

Legal Framework for the Use of Psychedelics in Switzerland

Cannabis Law Report

analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. percent annually to $9.8 billion by 2029. [1]

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. THC vs CBD.

THC 98